fbpx

Cotización de FDMT Noticias y Datos Financieros de 4D Molecular Therapeutics Inc

  ESCÁNER DE ACCIONES AMERICANAS DE TRADINGCERO.COM (VERSIÓN 1.0)      Hora Nueva York:
(2022-07-04)Formato Y-M-D
EARNINGS AYER: Ayer no hubo informes de resultados.
EARNINGS HOY: No hay informes de resultados previstos para hoy.
EARNINGS MAÑANA: No hay informes de resultados previstos para mañana.
IPOS AYER: Ayer no hubo IPOS.
IPOS HOY: No hay IPOS previstas para hoy.
IPOS MAÑANA: No hay IPOS previstas para mañana.
  
[ Escáners ]  1. Escáner de TODAS las Acciones.
  2. Escáner de PennyStocks (<= $10).
  3. Escáner de SmallCaps ($10 < y <= $80).
  4. Escáner de LargeCaps ( > $80).
     
[ Screener ]  >> Screener de TradingCero.com
     
[ Calendario de Earnings ]  >> Empresas que publicarán sus Informes de Resultados próximamente
     
[ Calendario de IPOS ]  >> Empresas que debutarán en WallStreet próximamente
     
[ Industrias / Sectores ]  >> Listado de Insdustrias y Sectores en WallStreet
     
[ Panel Predictivo ]  >> Acceso restringido
     
[ Descarga de Informes ]  >> Acceso restringido
     
[ Registro de Cambios ]  >> Registro de Cambios en el Escáner.
     

[ PÁGINA ACTUALIZADA EL 2022-07-04 23:17:20 hrs (New York) ]

Nombre:Nombre de la Empresa, Número de Empleados y web si está disponible
     4D Molecular Therapeutics Inc     Empleados: 83     Web Disponible
Industria:Industria a la que pertenece la Empresa
     Biological Product except Diagnostic Manufacturing
Sector:Sector al que pertenece la Empresa
     Manufacturing
Market Cap.:Capitalización de Mercado de la Empresa
     242.35 M
Insider Own:Porcentaje de Acciones que poseen los Socios de la Empresa
     6.2 %
Shares:Número total de Acciones de la Empresa
     32.23 M
Float:Flotante (Acciones disponibles para comprar/vender) de la Empresa
     28.57 M
Short Float:Porcentaje de Acciones en Corto de los Inversores sobre la Empresa
     6.94 %
Volumen:Volumen de operaciones de la última sesión de mercado sobre la Empresa
     0.13 M
Vol. Medio:Volumen Medio Diario de operaciones realizadas en el Mercado sobre la Empresa
     0.27418 M
Último %:Cambio en porcentaje: Diario, Semanal, Mensual y Anual de la Empresa
     -0.3 %     Semanal %:     -7.92 %     Mensual %:   -8.04 %     Anual %:   1 %
TODAS LAS NOTICIAS DE [ FDMT ]
FECHA / HORA     ÚLTIMAS NOTICIAS
2022-06-28 16:23:00    
>> Biotech champion QB3 leader Reg Kelly to retire ...Biotech champion QB3 leader Reg Kelly to retire
2022-06-02 16:02:00    
>> 4D Molecular Therapeutics to Participate in Upcoming June Investor Conferences ...4D Molecular Therapeutics to Participate in Upcoming June Investor Conferences
2022-05-14 08:19:00    
>> We re Not Very Worried About 4D Molecular Therapeutics NASDAQ FDMT Cash Burn Rate ...We re Not Very Worried About 4D Molecular Therapeutics NASDAQ FDMT Cash Burn Rate
2022-05-12 17:35:00    
>> 4D Molecular Therapeutics Inc FDMT Reports Q1 Loss Lags Revenue Estimates ...4D Molecular Therapeutics Inc FDMT Reports Q1 Loss Lags Revenue Estimates
2022-05-12 16:01:00    
>> 4D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates ...4D Molecular Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Updates
2022-05-09 17:55:00    
>> Profound Medical PROF Reports Q1 Loss Lags Revenue Estimates ...Profound Medical PROF Reports Q1 Loss Lags Revenue Estimates
2022-05-05 16:02:00    
>> 4D Molecular Therapeutics to Participate in the BofA Securities 2022 Healthcare Conference ...4D Molecular Therapeutics to Participate in the BofA Securities 2022 Healthcare Conference
2022-05-05 15:00:00    
>> Analysts Estimate 4D Molecular Therapeutics Inc FDMT to Report a Decline in Earnings What to Look Out for ...Analysts Estimate 4D Molecular Therapeutics Inc FDMT to Report a Decline in Earnings What to Look Out for
2022-04-04 16:02:00    
>> 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1 2 Clinical Trial of 4D 710 an A101 AAV Vector based Aerosol delivered Genetic Med ...4D Molecular Therapeutics Announces First Patient Dosed in Phase 1 2 Clinical Trial of 4D 710 an A101 AAV Vector based Aerosol delivered Genetic Medicine for the Treatment of Cystic Fibrosis
2022-03-30 11:49:00    
>> 4D Molecular Therapeutics NASDAQ FDMT investors are sitting on a loss of 58 if they invested a year ago ...4D Molecular Therapeutics NASDAQ FDMT investors are sitting on a loss of 58 if they invested a year ago
2022-03-28 16:02:00    
>> 4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights ...4D Molecular Therapeutics Reports Full Year 2021 Financial Results and Operational Highlights
2022-02-22 16:02:00    
>> 4D Molecular Therapeutics Announces Resignation of Professor David Schaffer Ph D from the Companys Board of Directors ...4D Molecular Therapeutics Announces Resignation of Professor David Schaffer Ph D from the Companys Board of Directors
2022-02-11 16:03:00    
>> 4D Molecular Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference ...4D Molecular Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
2022-02-09 08:02:00    
>> 4D Molecular Therapeutics Announces Updated Interim Results from the 4D 310 Phase 1 2 Clinical Trial in Patients with Fabry Disease at the 18th Annual ...4D Molecular Therapeutics Announces Updated Interim Results from the 4D 310 Phase 1 2 Clinical Trial in Patients with Fabry Disease at the 18th Annual WORLDSymposium
2022-02-02 16:01:00    
>> 4D Molecular Therapeutics to Present Updated Clinical Data with 4D 310 in Fabry Disease Patients in Platform Presentation at the 18th Annual WORLDSymp ...4D Molecular Therapeutics to Present Updated Clinical Data with 4D 310 in Fabry Disease Patients in Platform Presentation at the 18th Annual WORLDSymposium
2022-01-18 10:11:00    
>> 16 unloved stocks ripe for a rally Bank of America ...16 unloved stocks ripe for a rally Bank of America
2022-01-10 08:02:00    
>> 4D Molecular Therapeutics Announces FDA Fast Track Designation Granted to 4D 125 for the Treatment of X linked Retinitis Pigmentosa ...4D Molecular Therapeutics Announces FDA Fast Track Designation Granted to 4D 125 for the Treatment of X linked Retinitis Pigmentosa
2022-01-06 16:03:00    
>> 4D Molecular Therapeutics Announces First Patient Dosed in Phase 1 2 Clinical Trial of 4D 150 a Dual Transgene Intravitreal Gene Therapy for Patients ...4D Molecular Therapeutics Announces First Patient Dosed in Phase 1 2 Clinical Trial of 4D 150 a Dual Transgene Intravitreal Gene Therapy for Patients with wet AMD
2021-11-29 16:00:00    
>> Bright Peak Therapeutics Appoints Jacob Chacko M D as Chair of its Board of Directors ...Bright Peak Therapeutics Appoints Jacob Chacko M D as Chair of its Board of Directors
2021-11-25 05:52:00    
>> What You Need To Know About 4D Molecular Therapeutics Inc s NASDAQ FDMT Investor Composition ...What You Need To Know About 4D Molecular Therapeutics Inc s NASDAQ FDMT Investor Composition
2021-11-23 16:05:00    
>> 4D Molecular Therapeutics to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference ...4D Molecular Therapeutics to Participate in the Upcoming Evercore ISI HealthCONx 2021 Conference
2021-11-15 06:01:00    
>> 10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund ...10 Best Biotech Stocks to Buy According to Mark Lamperts Biotechnology Value Fund
TODOS LOS TWEETS [ FDMT ]
HORA USUARIO TWEET
2022-07-01 14:00:59 MONSTER2000
fdmt nasdaq stock rating changed to hold 4d molecular therapeutics incticker is 1931 off the historical supp ...fdmt nasdaq stock rating changed to hold 4d molecular therapeutics incticker is 1931 off the historical supp
2022-06-22 12:28:40 PRICETARGET.IO
fdmt price target update initiated by jefferies financial groupprice target 22day quotechange 738 1 ... fdmt price target update initiated by jefferies financial groupprice target 22day quotechange 738 1
2022-06-17 13:17:01 MONSTER2000
fdmt nasdaq stock rating changed to hold 4d molecular therapeutics incticker is 1693 off the historical supp ...fdmt nasdaq stock rating changed to hold 4d molecular therapeutics incticker is 1693 off the historical supp
2022-06-15 12:25:59 MONSTER2000
fdmt nasdaq stock rating changed to hold 4d molecular therapeutics inc currently 1613 off the historical sup ...fdmt nasdaq stock rating changed to hold 4d molecular therapeutics inc currently 1613 off the historical sup
2022-06-14 11:04:49 EBONIEHUHN
fdmt nasdaq stock rating changed to strong buy 4d molecular therapeutics incticker is 1765 off the historica ...fdmt nasdaq stock rating changed to strong buy 4d molecular therapeutics incticker is 1765 off the historica
2022-06-13 10:18:46 BILLIONAIRECLUBCOLLC.COM
12 health care stocks moving in mondays premarket session ...12 health care stocks moving in mondays premarket session
2022-06-10 10:09:48 YUZHU
rt mchilberg tracking group stocks that have pcash lt10 market cap cash on hand is 10fixx 048dtil 074fdmt 080crbu 092cl ...rt mchilberg tracking group stocks that have pcash lt10 market cap cash on hand is 10fixx 048dtil 074fdmt 080crbu 092cl
2022-06-10 10:08:15 MARTY CHILBERG
tracking group stocks that have pcash lt10 market cap cash on hand is 10fixx 048dtil 074fdmt 080crbu 092clls 095n19 ...tracking group stocks that have pcash lt10 market cap cash on hand is 10fixx 048dtil 074fdmt 080crbu 092clls 095n19
2022-06-03 06:03:08 INTRATIO
fdmt ...fdmt
2022-06-02 16:02:26 YELPFUL STOCK ALERTS
fdmt 4d molecular therapeutics to participate in upcoming june investor conferencesstock news alerts in bio ...fdmt 4d molecular therapeutics to participate in upcoming june investor conferencesstock news alerts in bio
2022-05-16 08:00:09 MONSTER2000
fdmt nasdaq stock rating changed to strong buy 4d molecular therapeutics inc ...fdmt nasdaq stock rating changed to strong buy 4d molecular therapeutics inc
2022-05-05 10:34:18 MONSTER2000
fdmt nasdaq stock rating changed to strong buy 4d molecular therapeutics inc ...fdmt nasdaq stock rating changed to strong buy 4d molecular therapeutics inc
2022-05-04 11:03:54 BRENDAN
anyhow i think the case for fdmt is sufficiently straightforward that the stock will be bid up before the fabryw ...anyhow i think the case for fdmt is sufficiently straightforward that the stock will be bid up before the fabryw
2022-05-02 08:51:04 CHARTMILL
a quick ratio of 1569 indicates that fdmt has no problem at all paying its short term obligations ...a quick ratio of 1569 indicates that fdmt has no problem at all paying its short term obligations
2022-04-22 08:09:32 MONSTER2000
fdmt nasdaq stock rating changed to sell 4d molecular therapeutics inc ...fdmt nasdaq stock rating changed to sell 4d molecular therapeutics inc
2022-04-20 08:36:21 MONSTER2000
fdmt nasdaq stock rating changed to sell 4d molecular therapeutics inc ...fdmt nasdaq stock rating changed to sell 4d molecular therapeutics inc
2022-04-14 08:10:55 MONSTER2000
fdmt nasdaq stock rating changed to strong sell 4d molecular therapeutics inc ...fdmt nasdaq stock rating changed to strong sell 4d molecular therapeutics inc
2022-04-13 16:02:27 TROOPER.TRADING
signs of a reversal and a failed 52week low for these stocks today fdmt xflt amsc cue amam scyx vinc zest ...signs of a reversal and a failed 52week low for these stocks today fdmt xflt amsc cue amam scyx vinc zest
2022-04-11 12:15:34 TRADER PLUS
build your trading deskfdmt fdmt ... build your trading deskfdmt fdmt
2022-04-05 10:25:14 SHORT TRADER
fdmt nasdaq stock rating changed to sell 4d molecular therapeutics inc ...fdmt nasdaq stock rating changed to sell 4d molecular therapeutics inc
2022-04-04 07:37:46 RALPH
stocks researching fabry disease include avro fdmt fold frln pfe phar plx qure sgmo sgtx sny ...stocks researching fabry disease include avro fdmt fold frln pfe phar plx qure sgmo sgtx sny
2022-04-01 07:21:06 US BANKING NEWS
q1 2022 eps estimates for 4d molecular therapeutics inc fdmt increased by svb leerink ...q1 2022 eps estimates for 4d molecular therapeutics inc fdmt increased by svb leerink
2022-03-29 08:53:29 MIDEAST TIMES
4d molecular therapeutics fdmt issues quarterly earnings results ...4d molecular therapeutics fdmt issues quarterly earnings results
2022-03-28 10:26:33 MONSTER2000
fdmt nasdaq stock rating changed to buy 4d molecular therapeutics inc ...fdmt nasdaq stock rating changed to buy 4d molecular therapeutics inc
2022-03-25 11:29:31 FRED JACKSON
fdmt join free today for a 10day trial utilizing our stock amp option alerts advisor experience technology mar ...fdmt join free today for a 10day trial utilizing our stock amp option alerts advisor experience technology mar
2022-03-23 10:43:19 NAKAJIMA KOICHI
rt marcjacksonla jnj mor incy bmy nvax pfe osur fdmt mrk apto clbs argx vblt aptx navb celc rmed daily biotech pulse pf ...rt marcjacksonla jnj mor incy bmy nvax pfe osur fdmt mrk apto clbs argx vblt aptx navb celc rmed daily biotech pulse pf
2022-03-23 10:37:12 BENZINGA
rt marcjacksonla jnj mor incy bmy nvax pfe osur fdmt mrk apto clbs argx vblt aptx navb celc rmed daily biotech pulse pf ...rt marcjacksonla jnj mor incy bmy nvax pfe osur fdmt mrk apto clbs argx vblt aptx navb celc rmed daily biotech pulse pf
2022-03-23 10:32:17 BIO & TECH STOCK FOCUS
jnj mor incy bmy nvax pfe osur fdmt mrk apto clbs argx vblt aptx navb celc rmed daily biotech puls ...jnj mor incy bmy nvax pfe osur fdmt mrk apto clbs argx vblt aptx navb celc rmed daily biotech puls
[ [ Advertencia de riesgo ] ]

 Por favor, recuerda que el Trading es una actividad que pone en riesgo tu dinero y antes de hacerlo debes entender y aceptar los riesgos que eso supone. TradingCero.com no ofrece recomendaciones sobre Inversión ni sobre compra o venta de acciones ni de ningún activo financiero.


TradingCero.com es una web que ofrece información sobre los mercados financieros y Criptodivisas - información de la que no nos responsabilizamos si tuviera algún error - además de publicar cursos de Trading que nos parezcan de calidad e interesantes para nuestros lectores. TODA la información que compartimos así como las sesiones de TRADING que hacemos en nuestro CANAL DE YOUTUBE es SÓLO con FINES EDUCATIVOS.


Es posible que la información mostrada en la Web de TradingCero.com y en el Escáner de Acciones Americanas contenga errores de los que no nos responsabilizamos. Usamos fuentes de información de distintos proveedores por lo que no nos podemos hacer responsables de los errores contenidos en dicha información. Si ves algún error en esta web o en los datos que muestra, por favor, escríbemos un email a pablo@tradingcero.com y lo corregiremos lo antes posible.


TradingCero.com forma parte del programa de afiliados de la Escuela de Trading Tradenet.com y como tal, no nos podemos responsabilizar de los errores o problemas incluídos en sus paquetes formativos y/o servicios profesionales que ofrezca como Escuela de Trading.


Puedes consultar nuestro aviso legal, política de privacidad y política de cookies cuándo lo desees !